In a recent RSDSA-supported study published in BMC Molecular Medicine, scientists describe, for the first time, two biological subtypes of CRPS type 1 that are consistent across both skin and blood.
This study identified two potential biological subgroups of CRPS type 1 in women through skin and blood transcriptomic profiling, advancing the understanding of CRPS. This could facilitate the development of targeted treatments for CRPS type 1.
Learn more and read the full study here.
